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Abstract 
Background: Arterial stiffness may contribute to late-life depression via cerebral 
microvascular damage, but evidence is scarce. No longitudinal study has evaluated the 
association between arterial stiffness and risk of depressive symptoms. We therefore 
investigated the association between carotid artery stiffness and incident depressive symptoms 
in a large community-based cohort study.  
 
Methods: This longitudinal study included 7,013 participants (mean age 59.7 (SD 6.3); 
35.8% women) free of depressive symptoms at baseline. Carotid artery stiffness (high-
resolution echotracking) was determined at baseline. Presence of depressive symptoms was 
determined at baseline and at 4 and 6 years of follow-up, and was defined as a score ≥7 on the 
validated Q2DA questionnaire and/or new use of antidepressant medication. Logistic 
regression and generalized estimating equations were used. 
 
Results: In total, 6.9% (n=484) of the participants had incident depressive symptoms. 
Individuals in the lowest tertile of carotid distensibility coefficient (indicating greater carotid 
artery stiffness) compared to those in the highest tertile had a higher risk of incident 
depressive symptoms (odds ratio: 1.43, 95% confidence interval: 1.10-1.87), after adjustment 
for age, sex, living alone, education, lifestyle, cardiovascular risk factors and baseline Q2DA 
scores. Results were qualitatively similar when we used carotid Young’s elastic modulus as a 
measure of carotid stiffness instead of carotid distensibility coefficient, and when we used 
generalized estimating equations instead of logistic regression.   
 
Conclusions: Greater carotid stiffness is associated with a higher incidence of depressive 
symptoms. This supports the hypothesis that carotid stiffness may contribute to the 
development of late-life depression.  
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Introduction 
By 2020, depression and depressive symptoms will be the largest contributors to global 
disability, after heart disease, in individuals aged ≥65 years (1, 2). Major depression occurs in 
2% of adults aged 65 years or older, and its prevalence rises with increasing age. In addition, 
10% to 15% of older adults have clinically significant depressive symptoms, even in the 
absence of major depression (3). Late-life depressive symptoms are associated with lower 
quality of life (4), functional impairment (5), 1.5- to 2-fold higher mortality risk (6, 7), and 2-
fold higher incidence of cardiovascular disease (8). However, current antidepressant 
medications are less effective (9, 10) and have more side-effects (11) in older compared to 
younger patients. More than 50% of older patients do not respond to such treatment (12). New 
effective interventions for prevention and treatment of late-life depression and depressive 
symptoms, therefore, need to be developed, which requires a better understanding of late-life 
depression risk factors.   
 
Arterial stiffness, which can be quantified non-invasively by measuring local distensibility of 
the carotid artery (13, 14), has been associated with a higher risk of cerebrovascular damage 
(15-17), and may contribute to the development of depressive symptoms. Although stiffening 
of arteries is an age-related phenomenon, it can occur in younger individuals, and, thus, 
arterial stiffness may contribute to depressive symptoms across the lifespan (18).   
 
Stiffening of large arteries impairs their cushioning function and increases pressure and flow 
pulsatility. This increased pulsatile load may transmit distally into the cerebral circulation 
and, thereby, contribute to cerebrovascular damage (19). Cerebrovascular damage, in turn, 
may predispose to depression via disruption of frontal and subcortical structures involved in 
mood regulation (20, 21). Most previous studies (22-25), but not all (26, 27), have found an 
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association between arterial stiffness and depressive symptoms (22-24) and depression (23-
25). However, these studies were all cross-sectional by design, precluding any conclusions 
about a temporal association between arterial stiffness and depressive symptoms. 
 
We therefore evaluated the longitudinal association between carotid stiffness and incident 
depressive symptoms in a large community-based cohort study of individuals aged 50-75 
years at baseline.  
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Methods and Materials 
 
Study design 
The Paris Prospective Study 3 (PPS3; n=10,157) is a longitudinal cohort study on novel 
markers for phenotypes of cardiovascular disease. The design and main objectives of PPS3 
have been described previously (28). In brief, individuals aged between 50-75 years were 
recruited at the Centre d’Investigations Préventives et Cliniques (IPC), a large preventive 
medical center in Paris (France), between June, 2008 and June, 2012. The IPC is one of the 
largest preventive medical centers in France and conducts free medical examinations (20,000-
25,000 examinations/year) among all working and retired employees and their families. The 
IPC is subsidized by the French National Insurance System for salaried workers. The Ethics 
Committee of the Cochin Hospital (Paris, France) approved the study. In addition, PPS3 was 
registered in the World Health Organization international clinical trial registry platform 
(NCT00741728). 
 
Carotid stiffness 
Carotid stiffness was determined using a high-resolution echotracking system (Artlab, Esaote, 
Maastricht, the Netherlands), as described previously (29). All measurements were done in a 
core-lab by trained vascular technicians unaware of the participants’ clinical status. Briefly, 
we used a 10 MHz 128 transducer linear array probe and performed the measurements on a 4 
cm segment of the right common carotid artery (1 cm proximal to the bifurcation) throughout 
the cardiac cycle for 6 seconds. The system allows real-time radiofrequency signal analysis 
with operator-independent determination of carotid diameter and mean intima-media 
thickness. Distension was measured on 14 lines at high-pulsed radiofrequency (600 Hz). The 
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carotid distensibility coefficient (DC) was calculated according to the following equation: 
ΔLCSA / LCSA ∙ PP, where LCSA is diastolic lumen cross-sectional area, ΔLCSA is stroke 
change in lumen area, and PP is local pulse pressure estimated from the carotid distension 
waveform. In addition, Young’s elastic modulus (YEM) was calculated as 3 ∙ (1+LCSA / 
WCSA) / DC, where WCSA is wall cross-sectional area. Carotid DC represents the elasticity 
of the artery as a whole, whereas carotid YEM represents the stiffness of the arterial wall 
material. These indices are correlated, but carotid DC varies with carotid diameter and intima-
media thickness, whereas carotid YEM is independent of artery structure. Please note that 
lower values of carotid DC, but higher values of carotid YEM reflect greater carotid stiffness. 
The reproducibility of carotid artery stiffness measurements has been demonstrated 
previously (30). A description of the data quality control of these measurements in PPS3 is 
provided in the online supplemental material. 
 
Depressive symptoms 
Depressive symptoms were assessed at baseline and at 4 and 6 years of follow-up using the 
13-item Questionnaire of Depression 2nd version, Abridged (QD2A) (31). The QD2A is a 
validated French questionnaire specifically designed for assessment of depressive symptoms 
in community studies and has a high internal consistency (α=0.91) (the questionnaire is 
provided in the supplemental material) (31). Participants were required to give a yes/no 
answer to each of the 13 items regarding their current emotional state. Response options can 
generate a continuous score ranging from 0 (no symptoms) to 13 (all symptoms). A QD2A 
score ≥7 indicates a high probability for a major depressive disorder (sensitivity: 81%, 
specificity: 96%) (31). In addition, information on the use of antidepressants (ATC codes: 
N06AA-NO6AX) was obtained at baseline, and at 4 and 6 years of follow-up. At baseline, a 
medical doctor checked current medication during a face-to-face interview with participants. 
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At follow-up, use of antidepressant medication was assessed by questionnaire. Presence of 
depressive symptoms was defined as a QD2A cut-off score of ≥7 or use of antidepressant 
medication (irrespective of indication). Prior history of depression or any other psychiatric 
disease was self-reported in the general health questionnaire (see below). 
 
Covariates 
Self-administered questionnaires were used to obtain information on education level, smoking 
behavior (categories: never, former and current), physical activity, dietary habits, alcohol 
consumption, perceived stress and medical history. We divided education level into three 
categories: 1) low (no or primary education); 2) intermediate (secondary education), and 3) 
high (higher education or university). The validated Baecke score was used to estimate overall 
physical activity (higher scores indicating higher levels of physical activity) (32). Dietary 
habits were evaluated using a semi-quantitative validated 18-item food frequency 
questionnaire (33). Dietary habits were classified as defined by the American Heart 
Association as ideal, intermediate or poor, as described previously (34). Alcohol consumption 
was categorized as never, 1-2 or >2 units/day. Perceived stress was measured with the 4-item 
Perceived Stress Scale (35). Presence of any sleep disorder (self-reported), excessive daytime 
sleepiness (as determined by the Epworth sleepiness scale (36)), proxy for sleep-disordered 
breathing (based on questions of the Berlin questionnaire, as described previously (37)), and 
insomnia symptoms (using questions from the Pittsburgh sleep quality index (38)) were also 
measured. Blood pressure was recorded using an Omron 705 C oscillometric device and an 
appropriate sized cuff after 10 min of supine rest. Hypertension was defined by a blood 
pressure of ≥140/90 mmHg and/or use of antihypertensive medication. Fasting glucose and 
lipid levels were measured, as described previously (28). Prior cardiovascular disease was 
defined by a self-reported history of stroke, myocardial infarction and/or angina pectoris. 
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Diabetes was defined by use of glucose-lowering medication and/or a fasting blood glucose 
≥7 mmol/L.  
 
Analytic sample 
Of the 10,157 participants included in PPS3, 46 had missing data on baseline depressive 
symptoms, 877 had missing data on arterial stiffness, and another 184 had missing data on 
potential confounders. In the remaining 9,050 participants, 1,172 (13.0%) had missing data on 
depressive symptoms at both follow-up examinations. In the remaining 7,878 participants, we 
excluded 865 individuals (11.0%) with depressive symptoms at baseline (i.e. QD2A score ≥7 
and/or use of antidepressant medication). Thus, the final study sample consisted of 7,013 
participants. This comprised 2,866 individuals with data on one follow-up examination (either 
at 4 year, n=2,665, or at 6 year, n=201) and 4,147 individuals with data on two follow-up 
examinations at the time of analysis. Participants with missing data for the present analysis, 
compared to those included in the analysis, were more likely to be younger (59.3 years versus 
59.7 years), less educated (primary school or less: 40.7% versus 29.0%) and current smokers 
(19.9% versus 13.6%), and to have diabetes (6.2% versus 3.8%), prior cardiovascular disease 
(2.9% versus 1.8%), hypertension (41.7% versus 35.3%) and a higher body mass index (25.7 
kg/m2 versus 25.1 kg/m2; all P-values <.05). 
 
Statistical analysis 
We report the results comparing those individuals in the highest sex-specific tertile of carotid 
stiffness to those in the lowest sex-specific tertile of carotid stiffness. We used logistic 
regression to estimate odds ratios (ORs) and 95% confidence intervals (95%CIs) for the 
association between baseline carotid DC or carotid YEM and incident depressive symptoms. 
In addition, we used generalized estimating equations (GEE) with an exchangeable 
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correlation structure and robust standard errors to estimate odds ratios (ORs) and 95%CIs for 
the association between baseline carotid DC and carotid YEM and presence of depressive 
symptoms at 4 and/or 6 years at follow-up. GEE is a method for longitudinal data analysis 
that takes into account the correlation of repeated measurements within individuals over time 
(39). We adjusted the analyses for the following potential confounders selected based on 
previous literature (22-27): age at entry, sex, living alone, education level, smoking, systolic 
and diastolic blood pressure, heart rate, diabetes, total/HDL cholesterol ratio, prior 
cardiovascular disease, body mass index, physical activity and use of antihypertensive and/or 
lipid-modifying medication at baseline (model 1), and additionally for baseline Q2DA scores 
(model 2).  
 
We examined interactions with age and sex, but none were statistically significant (all P-
values for interaction >.10). Results are therefore reported without stratification for these 
factors.   
 
We did several additional analyses to test the robustness of our findings: 1) we repeated the 
analyses with depressive symptoms at follow-up defined as only a Q2DA score ≥7 as the 
outcome, irrespective of use of antidepressant medication; 2) we repeated the analyses after 
excluding individuals with prior cardiovascular disease or incident cardiovascular disease 
during follow-up; 3) we additionally adjusted the results for baseline dietary habits and 
alcohol consumption; 4) we additionally adjusted for perceived stress at baseline; 5) we 
repeated the analyses with adjustment for fasting glucose instead of diabetes; 6) we 
additionally adjusted for sleep disturbances, including any sleep disorder, excessive daytime 
sleepiness, proxy for sleep-disordered breathing and insomnia symptoms; 7) we repeated the 
analyses in individuals without a self-reported prior history of depression or any other 
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psychiatric disease; and 8) we repeated the analyses in individuals with complete data on 
depressive symptoms at both follow-up examinations.   
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Results 
The mean age of the study population at baseline was 59.7 (SD 6.3) years, and 35.8% were 
women (Table 1). In total, 6.9% (n=484) of the participants had incident depressive 
symptoms, of whom 72.1% (n=349) had a Q2DA score ≥7 and 31.6% (n=153) had started 
using antidepressant medication. The mean time between the baseline and first follow-up 
examination was 4.1 years (SD 0.2), and between baseline and the second follow-up 
examination 6.1 years (SD 0.2).  
 
Results of the logistic regression analysis showed that individuals in the lowest tertile of 
carotid DC (for women: <17.5 10-3/kPa, and for men: <18.0 10-3/kPa) compared to those in 
the highest tertile (for women: >24.7 10-3/kPa, and for men: >24.3 10-3/kPa) had a higher risk 
of incident depressive symptoms (OR 1.40, 95%CI 1.08-1.81), after adjustment for potential 
confounders (Figure 1). Further adjustment for baseline Q2DA scores did not materially 
change this result (Figure 1). The ORs and 95% CIs for all factors contained in the regression 
model are provided in the supplemental material Table S1. In addition, individuals in the 
highest tertile of carotid YEM (for women: >0.504 10-3*kPa, and for men: >0.536 10-3*kPa) 
compared to those in the lowest tertile (for women: <0.363 10-3*kPa, and for men: < 0.389 10-
3*kPa) had a higher risk of incident depressive symptoms (OR 1.28, 1.00-1.66), after 
adjustment for potential confounders and baseline Q2DA scores (Figure 1). Similarly, results 
of the longitudinal analyses (GEE) showed that individuals with lower carotid DC or higher 
carotid YEM had higher odds of depressive symptoms at follow-up, although the results for 
carotid YEM were not statistically significant (fully adjusted ORs: for carotid DC 1.35, 
95%CI 1.04-1.76, and for carotid YEM 1.23, 95%CI 0.96-1.57; Supplemental Figure S1). 
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The results of the additional analyses are shown in Figure 2 and Table S2. Results were 
qualitatively similar when we repeated the analyses with depressive symptoms at follow-up 
defined only as a Q2DA score ≥7, irrespective of use of antidepressant medication; when we 
excluded individuals with prior cardiovascular disease or incident cardiovascular events 
during follow-up (total n=252); after additional adjustments for dietary habits and alcohol 
consumption, or perceived stress, or fasting glucose instead of diabetes; after exclusion of 
individuals with a prior history of depression or any other psychiatric disease (n=520); or 
when we repeated the analysis in individuals with complete data on depressive symptoms at 
both follow-up examinations (n=4,147) (Figure 2). In addition, results did not materially 
change after adjustments for presence of any sleep disorder, excessive daytime sleepiness, 
proxy for sleep-disordered breathing or insomnia symptoms (supplemental Table S2). 
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Discussion 
In the present large community-based cohort study, greater carotid stiffness was associated 
with a higher incidence of depressive symptoms, after accounting for socio-economic status, 
lifestyle and cardiovascular risk factors. To our knowledge, this is the first longitudinal study 
to date demonstrating that greater carotid stiffness is a risk factor for incident depressive 
symptoms. 
 
The present longitudinal study extends previous population-based studies, including the Age, 
Gene / Environment susceptibility (AGES)-Reykjavik study (n=2,058) (22), Rotterdam study 
(n=3,704) (23) and Maastricht study (n=2,757) (24), that evaluated the cross-sectional 
association between arterial stiffness and depressive symptoms. These studies found that 
greater aortic or carotid stiffness is associated with presence of depressive symptoms (22-24) 
and depression (23, 24), but their cross-sectional design did not allow conclusions about the 
direction of this association.  
 
Stiffening of the carotid artery (or other elastic arteries for which the carotid artery may serve 
as a proxy) may contribute to cerebral microvascular damage and subsequent depressive 
symptoms via an increased pulsatile load on the cerebral microcirculation (19, 40). This 
increased load may directly cause cerebral ischemia and hemorrhage. Further, the increased 
pulsatile load may induce a hypertrophic remodeling response and rarefaction of small 
cerebral arteries, which, in turn, may lead to chronic ischemia (19, 40). It is likely that 
ischemia may damage frontal and subcortical structures or their connecting pathways 
involved in mood regulation and, hence, may lead to depressive symptoms (20, 21, 41). In 
accordance, a previous meta-analysis found that greater arterial stiffness is associated with 
various MRI markers of cerebral small vessel disease (i.e. white matter hyperintensities, 
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cerebral microbleeds and lacunes) (42), and such MRI markers have been shown to be 
associated with a higher incidence of depressive symptoms (43). Furthermore, cross-sectional 
data from the AGES-Reykjavik Study (22) showed that the association between greater 
arterial stiffness and presence of depressive symptoms was in part explained, or mediated, by 
markers of cerebral small vessel disease, i.e. white matter hyperintensities and lacunes.  
 
However, other underlying mechanisms may explain the observed associations in the present 
study. First, other factors may be independently related to both carotid stiffness and 
depressive symptoms, such as stress, unhealthy lifestyle habits and cardiovascular disease. 
However, the associations between carotid stiffness and incident depressive symptoms were 
independent of perceived stress, physical activity, smoking, dietary habits and alcohol 
consumption. Furthermore, results did not materially change after excluding individuals with 
cardiovascular disease. Second, the association between arterial stiffness and incident 
depressive symptoms may exist because late-life depressive symptoms represent an early 
manifestation of (vascular) dementia (44). However, we had no available information on 
cognitive performance or dementia in the present study, and this issue requires further 
investigation. Third, it has been suggested that associations between cerebrovascular damage 
and depression may be (partially) attributable to apathy (45). Apathy overlaps with depression 
but may be a distinct syndrome (46). In the present study, we did not measure apathy, and this 
issue also requires further study. Fourth, early adversity may explain part of the observed 
associations, because early adversity has been related to both arterial stiffness (47) and 
depression (48). However, no data on early adversity was available in our study, and this 
requires further study. Fifth, other biological mechanisms may underlie both arterial stiffness 
and depressive symptoms. For instance, oxidative stress and low-grade inflammation are 
related to arterial stiffness (49, 50), cerebral white matter integrity (51), cerebral small vessel 
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damage (52), and depression (53). In addition, recent studies found that lower brain-derived 
neurotrophic factor (BDNF), an important risk factor for depression, is related to greater 
carotid intima-media thickness (54) and higher pulse pressure (a surrogate measure for greater 
arterial stiffness) (55). However, data on oxidative stress, low-grade inflammation, and BDNF 
were not available in the present study. 
 
The present results did not differ according to age and sex. In accordance, most previous 
studies on arterial stiffness and depression (22, 23, 26), that were all cross-sectional in design, 
did not find an interaction for sex. Only one previous study, The Maastricht Study (24), 
evaluated interaction with age. In contrast to our results, this study found a stronger 
association between aortic stiffness and presence of depression in younger (<60 years) as 
compared to older individuals (≥60 years). This inconsistent finding between The Maastricht 
Study and our study may be due to differences in the source of populations investigated 
(preventive care center vs. population-based), arterial stiffness measurement (carotid artery 
stiffness vs. aortic stiffness), study design (longitudinal vs. cross-sectional) or the result of the 
play of chance, and requires further study. 
 
From a clinical point of view, the association between carotid stiffness and incident 
depressive symptoms is important because it suggests that arterial stiffness is a target for 
prevention strategies of vascular-related late-life depression. Intervention studies suggest that 
lifestyle modifications, such as weight loss, exercise and dietary modifications, may have a 
beneficial effect on both arterial stiffness (56, 57) and depression (58). In addition, drugs, 
such as angiotensin receptor-2 agonists (e.g. compound 21), renin-angiotensin aldosterone 
system (RAAS) inhibitors and statins, may lower arterial stiffness, possibly beyond any blood 
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pressure-lowering effects (56, 57). Pharmaco-epidemiologic data indicate that RAAS 
inhibitors (59) and statins (60) may also have antidepressant properties.  
 
Strengths of the present study include the state-of-the-art imaging of the carotid artery to 
estimate carotid stiffness, the longitudinal design and the wide set of potential confounders in 
a large community-based study population.  
 
The present study has also several limitations. First, depressive symptoms were assessed by a 
self-reported questionnaire, and not by a structured interview. Therefore, there was no 
available information on clinical depression. Nevertheless, the sensitivity and specificity of 
questionnaire measures compared with a depression diagnosis based on a structured interview 
are high (31). Furthermore, depressive symptoms, even in the absence of a diagnosis of major 
depression, are associated with 1.5- to 2-fold higher mortality (6, 7). Second, misclassification 
of incident depressive symptoms may have occurred because antidepressant medication can 
also prescribed for conditions other than depression. However, the results were qualitatively 
similar when Q2DA scores alone were used as the outcome. Third, we had no information on 
presence of depressive symptoms in the intervals between follow-up examinations, and this 
may have led to an underestimation of the association between carotid stiffness and incident 
depressive symptoms. Finally, our study population was relatively healthy and included 
mostly individuals of Caucasian ethnicity. The results may therefore not be generalizable to 
clinical samples and other ethnicities. 
 
In conclusion, the present study shows that greater carotid stiffness is associated with a higher 
incidence of depressive symptoms. This suggests that carotid stiffness may contribute to the 
development of late-life depression.  
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Figure legends 
 
Figure 1. Association between carotid distensibility coefficient (DC; tertile 1 vs. tertile 3) 
and Young’s elastic modulus (YEM; tertile 3 vs. tertile 1) and incident depressive 
symptoms.  
Model 1 adjusted for age, sex, living alone, education level, smoking, systolic and diastolic 
blood pressure, heart rate, diabetes, total/HDL cholesterol ratio, prior cardiovascular disease, 
body mass index, physical activity, and use of antihypertensive and/or lipid-modifying 
medication. Model 2 additionally adjusted for baseline Q2DA score.  
 
Figure 2. Additional analyses. Association between carotid distensibility coefficient (DC; 
tertile 1 vs. tertile 3) and Young’s elastic modulus (YEM; tertile 3 vs. tertile 1) and 
incident depressive symptoms  
1) Depressive symptoms at follow-up defined only as a Q2DA score ≥7, irrespective of use of 
antidepressant medication; 2) Individuals excluded with prior cardiovascular disease (CVD) 
or incident cardiovascular disease during follow-up (n=252); 3) Results additionally adjusted 
for dietary habits (ideal, intermediate or poor dietary habits as defined by the American Heart 
Association) and alcohol consumption (0, 0-2 and >2 units/day) (data missing in n=1,003); 4) 
Results additionally adjusted for perceived stress; 5) Results adjusted for fasting glucose 
instead of diabetes; 6) Individuals excluded with a self-reported history of prior depression or 
any other psychiatric disease (n=520); and 7) Analyses repeated in individuals with complete 
data on depressive symptoms at both follow-up examinations (n=4,147). All results are 
adjusted for age, sex, living alone, education level, smoking, systolic and diastolic blood 
pressure, heart rate, diabetes, and diastolic blood pressure, heart rate, diabetes, total/HDL 
cholesterol ratio, prior cardiovascular disease, body mass index, physical activity, use of 
antihypertensive and/or lipid-modifying medication, and baseline Q2DA scores. 
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Table 1. Baseline characteristics of the total study population, and according to incident 
depressive symptoms  
Data are mean (standard deviation) or % (n) as appropriate.  
 Total study 
population 
(n=7,013) 
Without incident 
depressive 
symptoms 
(93.1%, n=6,529) 
With incident 
depressive 
symptoms 
(6.9%, n=484) 
Baseline characteristics    
Age (years) 59.7 (6.3) 59.7 (6.3) 59.9 (6.7) 
Women 35.8 (2,509) 34.6 (2,258) 52.1 (251) 
Education  
   Low 
   Intermediate 
   High 
 
28.4 (1,989) 
29.3 (2,058) 
42.3 (2,966) 
 
28.1 (1,833) 
29.3 (1,915) 
42.6 (2,781) 
 
32.2 (156) 
29.5 (143) 
38.2 (185) 
Living alone 23.0 (1,616) 22.5 (1,470) 30.2 (146) 
Self-reported history of prior 
depression or any other psychiatric 
disease 
7.4 (520) 6.5 (424) 19.8 (96) 
Smoking 
   Never 
   Former  
   Current 
 
53.0 (3,719) 
34.0 (2,384) 
13.0 (910) 
 
53.1 (3,469) 
34.0 (2,221) 
12.9 (839) 
 
51.7 (250) 
33.7 (163) 
14.7 (71) 
Type 2 diabetes mellitus 3.8 (263) 3.6 (236) 5.6 (27) 
Prior cardiovascular disease 1.7 (116) 1.6 (104) 2.5 (12) 
Hypertension 35.1 (2,464) 35.2 (2,300) 33.9 (164) 
Systolic blood pressure (mmHg) 131 (16) 131 (16) 129 (16) 
Diastolic blood pressure (mmHg) 76 (9) 76 (9) 75 (10) 
Heart rate (bpm) 61 (9) 61 (9) 62 (9) 
Body mass index (kg/m2) 25.1 (3.5) 25.1 (3.5) 25.1 (4.1) 
Physical activity (Baecke score) 6.9 (1.5) 6.9 (1.5) 6.7 (1.5) 
Total cholesterol (mg/dL) 221 (35) 221 (35) 222 (39) 
HDL cholesterol (mg/dL) 58 (15) 58 (15) 60 (16) 
Antihypertensive medication 14.5 (1,016) 14.4 (938) 16.1 (78) 
Lipid-modifying medication 13.4 (941) 13.3 (867) 15.3 (74) 
Carotid stiffness 
Distensibility coefficient (10-3/kPa) 
Young’s elastic modulus (10-3*kPa) 
 
22.0 (7.9) 
0.493 (0.220) 
 
22.0 (7.9) 
0.492 (0.217) 
 
21.6 (8.1) 
0.502 (0.254) 
